Dear Editor, Although hereditary spherocytosis (HS) is a common disorder of the red cell membrane, it is diagnosed in only one third of affected infants during the first year of life [1] and rarely in the newborn period. The degree of hemolysis varies widely from patient to patient, even though the molecular defect appears to be similar [1] . In approximately two thirds of HS patients, inheritance is autosomal dominant. In this group of "typical" HS patients, nonsense and frameshift mutations of ankyrin are the most common cause [2] , followed by mutations in band 3 and ß spectrin [3] . Cases with autosomal recessive inheritance are due to defects in either alpha-spectrin or protein 4.2. Ankyrin is the principal binding site for spectrin on the red cell membrane; as a result, ankyrin deficiency leads to decreased incorporation of spectrin on the membrane. In approximately one third of patients with ankyrin deficiency, one ankyrin mRNA allele is virtually missing due to deletion, frameshift, or nonsense mutations that alter the transcription, processing, or stability of ankyrin mRNA [1, 4, 5] . Other ankyrin mutations in dominant hereditary spherocytosis include truncated variants and one nonexpressed isoform [6, 7] . Up to now, 55 distinct ankyrin mutations have been reported in human hereditary spherocytosis [8] .
We report on a male neonate who was admitted to our hospital because of pallor and tachypnea at the age of 4 weeks. On admission, blood count revealed low hemoglobin The peripheral blood smear showed spherocytes. Further laboratory investigations as tested with hypotonic NaCl dilutions and acidified glycerol lysis test showed the typical decreased osmotic resistance of red cells compatible with a spherocytosis.
Molecular genetic analyses of the patient and the parents were performed. A heterozygous de novo mutation E9X (p.Glu9Term, c.25G>T, GAA>TAA) in exon 1 of the ANK1 gene was detected in the patient. On the protein level (codon 9), the guanine/thymine substitution leads to an amino acid break (GAA codes for glutamic acid; TAA is a termination code). As the truncated amino acid chain is highly unstable, no anomalous ankyrin protein should be present in peripheral blood.
This case reports on a new de novo nonsense mutation in the ankyrin protein. In contrast to most affected infants, this mutation leads to severe hemolysis already in the newborn period [9] .
Because the mutation was not present in the patient's parents, we emanate from a dominant de novo mutation surfaced during the differentiation of one of the parents' germ cell line precursors, probably late in development. This is consistent to genetic studies in which, in most sporadic cases, a large number of de novo mutations arise in the maternal germ line [4] .
As often, the requirement for transfusion was transient [6, 9] . The patient reached sustained transfusion independence at an age of 6 months.
